newsfilter
← Latest News
PR Newswire·

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...